This site is intended for Healthcare professionals only.

Lupin launches generic conjunctivitis treatment medicine in US

Lupin launches generic conjunctivitis treatment medicine in US

New Delhi: Domestic pharma major Lupin Ltd on Wednesday said it has launched in the US market its generic version of Moxifloxacin Hydrochloride Ophthalmic solution used for treating bacterial conjunctivitis.

The launch follows receipt of approval from the US Food and Drug Administration (USFDA) earlier for Moxifloxacin Hydrochloride Ophthalmic solution 0.5 per cent, the company said in a statement.

The product is produced at Lupin’s Pithampur manufacturing facility, it added.

The medicine is generic equivalent of Novartis Pharms Corp’s Vigamox Ophthalmic solution.

READ  Glenmark recalls 100,000 bottles of anti-inflammatory drug over incorrect instrictions


Source: PTI
0 comment(s) on Lupin launches generic conjunctivitis treatment medicine in US

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted